These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32927080)

  • 21. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.
    d'Alessandro M; Carleo A; Cameli P; Bergantini L; Perrone A; Vietri L; Lanzarone N; Vagaggini C; Sestini P; Bargagli E
    Clin Exp Med; 2020 May; 20(2):207-216. PubMed ID: 31970550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.
    Veeraraghavan S; Latsi PI; Wells AU; Pantelidis P; Nicholson AG; Colby TV; Haslam PL; Renzoni EA; du Bois RM
    Eur Respir J; 2003 Aug; 22(2):239-44. PubMed ID: 12952254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis of interstitial lung disease (ILD) in patients with systemic sclerosis. The significance of broncho-alveolar lavage (BAL) --personal observations].
    Kopiński P; Korkosz M; Janowska E
    Folia Med Cracov; 1996; 37(3-4):51-66. PubMed ID: 9312535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute exacerbation of interstitial lung disease after procedures.
    Amundson WH; Racila E; Allen T; Dincer HE; Tomic R; Bhargava M; Perlman DM; Kim HJ
    Respir Med; 2019 Apr; 150():30-37. PubMed ID: 30961948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive surface phenotyping of alveolar macrophages in interstitial lung disease.
    Taylor ML; Noble PW; White B; Wise R; Liu MC; Bochner BS
    Clin Immunol; 2000 Jan; 94(1):33-41. PubMed ID: 10607488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases.
    Bergantini L; d'Alessandro M; Cameli P; Perrone A; Cekorja B; Boncompagni B; Mazzei MA; Sestini P; Bargagli E
    Eur J Intern Med; 2021 Jul; 89():76-80. PubMed ID: 33931268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of FIV infection on lung inflammatory cell populations recovered by bronchoalveolar lavage.
    Hawkins EC; Kennedy-Stoskopf S; Levy JK; Meuten DJ; Cullins L; Tompkins WA; Tompkins MB
    Vet Immunol Immunopathol; 1996 May; 51(1-2):21-8. PubMed ID: 8797273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage.
    Damjanov N; Ostojic P; Kaloudi O; Alari S; Guiducci S; Stanflin N; Nestorovic B; Knezevic J; Camiciottoli G; Porta F; Pistolesi M; Ibba-Manneschi L; Conforti ML; Candelieri A; Matucci Cerinic M
    Respiration; 2009; 78(1):56-62. PubMed ID: 18931474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
    Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for acute exacerbation following bronchoalveolar lavage in patients with suspected idiopathic pulmonary fibrosis: A retrospective cohort study.
    Abe M; Tsushima K; Ishii D; Shikano K; Yoshioka K; Sakayori M; Suzuki M; Hirasawa Y; Ishiwata T; Kawasaki T; Ikari J; Terada J; Tatsumi K
    Adv Respir Med; 2021; 89(2):101-109. PubMed ID: 33881153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease.
    Salonen J; Jansa S; Vähänikkilä H; Kaarteenaho R
    BMC Pulm Med; 2023 Jul; 23(1):236. PubMed ID: 37393286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer.
    Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
    Thorac Cancer; 2021 Jun; 12(11):1681-1689. PubMed ID: 33939332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of cytokines and chemokines in bronchoalveolar lavage fluid on acute exacerbation of fibrosing interstitial lung disease.
    Furuta K; Fujimoto D; Matsunashi A; Shibaki R; Taniya S; Tanaka M; Shimada Y; Nagata K; Tomii K; Yamamoto N
    Respir Med; 2024 Sep; 231():107721. PubMed ID: 38972608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
    Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
    Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High proportion of gamma-delta T cell receptor positive T cells in bronchoalveolar lavage and peripheral blood of HIV-infected patients with Pneumocystis carinii pneumonias.
    Kägi MK; Fierz W; Grob PJ; Russi EW
    Respiration; 1993; 60(3):170-7. PubMed ID: 7692576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
    Meyer KC; Raghu G
    Eur Respir J; 2011 Oct; 38(4):761-9. PubMed ID: 21540304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.
    Meyer KC; Raghu G; Baughman RP; Brown KK; Costabel U; du Bois RM; Drent M; Haslam PL; Kim DS; Nagai S; Rottoli P; Saltini C; Selman M; Strange C; Wood B;
    Am J Respir Crit Care Med; 2012 May; 185(9):1004-14. PubMed ID: 22550210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.